comparemela.com

Synthimed Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CCI clears Synthimed Labs proposal to buy ISLL, Essix Biosciences businesses

NCLAT stays bankruptcy proceedings against Ind-Swift

Ind-Swift was admitted for corporate insolvency on September 12 on a petition by trader creditor Allcare Containers claiming overdues of ₹3.12 crore, according to an order passed by the Chandigarh National Company Law Tribunal (NCLT). Last week, the NCLAT stayed the insolvency process till October 30 after the company said that it had settled the principal dues of Allcare but needed time to negotiate the terms of interest payment.

Argus, Khaitan act on Ind-Swift Laboratories sale of API and CRAMS businesses to Synthimed Labs

IndiaRF acquires Ind-Swift business for Rs 1,650 crore

IndiaRF acquires Ind-Swift business for Rs 1,650 crore
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Api: Piramal, Bain fund buys API, contract biz of Ind-Swift

India Business News: MUMBAI: Ind-Swift Labs said it will sell its active pharmaceutical ingredient (API) and contract research & manufacturing services (CRAMS) business to.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.